Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(14%)
Results Posted
40%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
1
14%
Ph not_applicable
2
29%
Ph phase_3
2
29%
Ph phase_2
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 32 (28.6%)
N/A2 (28.6%)

Trials by Status

recruiting114%
terminated114%
completed571%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_2

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

NCT05933499
completedphase_2

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

NCT00396279
completednot_applicable

Efficacy of a Once Daily Calcium and Vitamin D Fortified Food Product to Improve Bone Microarchitecture

NCT02375503
completednot_applicable

Evaluation of Calcium and Vitamin D Supplementation During Marine Corps Training

NCT02636348
completedphase_3

Osteoporosis Prevention With Low Dose Alendronate

NCT00463268
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05933499Phase 2

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

Recruiting
NCT00396279Phase 2

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Completed
NCT02375503Not Applicable

Efficacy of a Once Daily Calcium and Vitamin D Fortified Food Product to Improve Bone Microarchitecture

Completed
NCT02636348Not Applicable

Evaluation of Calcium and Vitamin D Supplementation During Marine Corps Training

Completed
NCT00463268Phase 3

Osteoporosis Prevention With Low Dose Alendronate

Completed
NCT00285090Phase 1

Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury

Terminated
NCT00404820Phase 3

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis

Completed

All 7 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7